Widthness LLC

Advanced Business and Technology – Intel® Xeon® and A.I. Powered

Drug Eluting Stents

1 min read

Browse Press Release: Coherent Market Insights

Drug Eluting Stents Market Size, Share, Growth, Technology Trend, Current Status By Major Key Vendors Boston Scientific Corporation, Medtronic, Plc, Abbott Laboratories, Biosensors International Group, Biotronik | Global Industry Grow At A Cagr Of 6.4% – 2027

A drug-eluting stent (DES) is a coronary stent which is a made up of wire that is designed to place into the arteries of patients suffering from atherosclerosis. This stent is used to hold the open artery in order to provide a drug that prevents blockage in the artery and increases the blood flow. Drug-eluting stents are basically used during coronary angioplasty procedures. Some of the types of drug-eluting stents are bare metal coronary artery stents, coronary artery restenosis, coronary artery stents, coronary revascularization, paclitaxel-eluting coronary artery stents, sirolimus-eluting coronary artery stents, and target vessel revascularization. […]

The owner of this website has made a commitment to accessibility and inclusion, please report any problems that you encounter using the contact form on this website. This site uses the WP ADA Compliance Check plugin to enhance accessibility.